Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
โ Scribed by Anna Suk-Fong Lok
- Book ID
- 108953968
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 517 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Most of you are aware that Dr. Jorge Gumucio has completed his tenure as editor of the HEPATOLOGY Elsewhere section. During his stewardship it has become a thoroughly enjoyable section for many of us to peruse. Not only are we able to keep in pace with all the developments in liver disease that are
Antibody to hepatitis C virus (anti-HCV) was detected in 18.7% of patients with hepatocellular carcinoma (HCC) and in 10.9% of controls (P<O.OOl). The corresponding prevalences of hepatitis B surface antigen (HBsAg) were 59.3% and 50.0% (F'CO.001). Using patients with non-hepatic disease as controls